320 related articles for article (PubMed ID: 1599922)
1. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
[TBL] [Abstract][Full Text] [Related]
2. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
3. Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins.
Chagas JR; Portaro FC; Hirata IY; Almeida PC; Juliano MA; Juliano L; Prado ES
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):63-9. PubMed ID: 7864830
[TBL] [Abstract][Full Text] [Related]
4. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
6. Horse urinary kallikrein, II. Effect of subsite interactions on its catalytic activity.
Araújo-Viel MS; Juliano MA; Oliveira L; Prado ES
Biol Chem Hoppe Seyler; 1988 May; 369(5):397-401. PubMed ID: 3166744
[TBL] [Abstract][Full Text] [Related]
7. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
[TBL] [Abstract][Full Text] [Related]
8. Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from Plasmodium falciparum and demonstration of their kininogenase activity.
Cotrin SS; Gouvêa IE; Melo PM; Bagnaresi P; Assis DM; Araújo MS; Juliano MA; Gazarini ML; Rosenthal PJ; Juliano L; Carmona AK
Mol Biochem Parasitol; 2013 Feb; 187(2):111-6. PubMed ID: 23354130
[TBL] [Abstract][Full Text] [Related]
9. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
10. Tetrapeptide substrates for the discrimination among kallikreins and other trypsin-like serine proteinases.
Prado ES; Araújo-Viel MS; Juliano MA; Juliano L; Stella RC; Sampaio CA
Biol Chem Hoppe Seyler; 1986 Mar; 367(3):199-205. PubMed ID: 3518738
[TBL] [Abstract][Full Text] [Related]
11. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
Gomes RA; Juliano L; Chagas JR; Hial V
Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human and porcine tissue kallikrein substrate specificities.
Del Nery E; Chagas JR; Juliano MA; Juliano L; Prado ES
Immunopharmacology; 1999 Dec; 45(1-3):151-7. PubMed ID: 10615005
[TBL] [Abstract][Full Text] [Related]
13. Determinants of tissue kallikrein cleavage specificity in the limited proteolysis of kininogens.
Prado ES; Chao J; Chagas JR; Juliano MA; Juliano L
Agents Actions Suppl; 1992; 38 ( Pt 1)():74-81. PubMed ID: 1466305
[TBL] [Abstract][Full Text] [Related]
14. Intramolecularly quenched fluorogenic tetrapeptide substrates for tissue and plasma kallikreins.
Chagas JR; Juliano L; Prado ES
Anal Biochem; 1991 Feb; 192(2):419-25. PubMed ID: 2035841
[TBL] [Abstract][Full Text] [Related]
15. Role of the S' subsites in serine protease catalysis. Active-site mapping of rat chymotrypsin, rat trypsin, alpha-lytic protease, and cercarial protease from Schistosoma mansoni.
Schellenberger V; Turck CW; Rutter WJ
Biochemistry; 1994 Apr; 33(14):4251-7. PubMed ID: 8155642
[TBL] [Abstract][Full Text] [Related]
16. Secondary substrate binding in aspartic proteinases: contributions of subsites S3 and S'2 to kcat.
Balbaa M; Cunningham A; Hofmann T
Arch Biochem Biophys; 1993 Nov; 306(2):297-303. PubMed ID: 8215428
[TBL] [Abstract][Full Text] [Related]
17. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.
Pimenta DC; Chao J; Chao L; Juliano MA; Juliano L
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):473-9. PubMed ID: 10191281
[TBL] [Abstract][Full Text] [Related]
18. Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids.
Melo RL; Barbosa Pozzo RC; Pimenta DC; Perissutti E; Caliendo G; Santagada V; Juliano L; Juliano MA
Biochemistry; 2001 May; 40(17):5226-32. PubMed ID: 11318645
[TBL] [Abstract][Full Text] [Related]
19. Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites.
Portaro FC; Cezari MH; Juliano MA; Juliano L; Walmsley AR; Prado ES
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):167-71. PubMed ID: 9173877
[TBL] [Abstract][Full Text] [Related]
20. Individual reaction steps in the release of kallidin from kininogen by tissue kallikrein.
Fiedler F; Hinz H; Lottspeich F
Adv Exp Med Biol; 1986; 198 Pt A():283-9. PubMed ID: 3643712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
